返回
Pelthos Therapeutics Inc（PTHS）價格
PTHS 股價走勢圖
PTHS 收益
Pelthos Therapeutics Inc
$23.06
-11.1%
$-2.88
收盤價：Jan 16, 16:00:00 GMT-5
$23.79
3.16%
$0.73
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$25.94
開盤價
$25.32
當日範圍
$23.06 - $25.7
52週區間
$9 - $54.29
交易量
16.9K
平均成交量
24.8K
每股盈餘 (TTM)
-12.80
股息收益率
--
市值
$73.5M
什麼是 PTHS？
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. The company is headquartered in Durham, North Carolina and currently employs 4 full-time employees. The company went IPO on 2024-02-16. The firm's lead product, ZELSUVMI (berdazimer) topical gel, 10.3%, is used in the treatment of molluscum contagiosum infections (molluscum) in adults and pediatric patients one year of age and older. In addition to ZELSUVMI, the Company has a pipeline of product candidates that utilize its proprietary nitric oxide-based technology platform, NITRICIL. The Company’s product Xepi (ozenoxacin) Cream, 1%, which is a non-fluorinated quinolone antimicrobial indicated for the topical treatment of impetigo. The firm is also evaluating the path forward for its existing NaV 1.7 development programs for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks.